BREAKING
BioNTech (BNTX) Posts Q4 Loss of $-1.25/Share as Revenue Falls 23.8% YoY to $907.4M 4 minutes ago Cullinan Therapeutics (CGEM) Reports Q4 Loss of $0.77 Per Share, Flat Year-Over-Year 9 minutes ago Tenax Therapeutics Inc (TENX) Reports Q4 Earnings 11 minutes ago Opus Genetics Inc. (IRD) Reports FY25 Earnings 15 minutes ago Apyx Medical (APYX) Q4 Revenue Jumps 34.8% to $19.2M, Loss Narrows to $0.06/Share 21 minutes ago Cullinan Therapeutics Inc (CGEM) Reports Q4 Earnings 27 minutes ago Prelude Therapeutics Inc (PRLD) Reports Wider Loss for FY25 vs. Estimates 34 minutes ago Prelude Therapeutics (PRLD) Q4 Loss Widens 616.7% to $1.29/Share as Revenue Climbs to $12.1M 38 minutes ago Opus Genetics (IRD) Reports $0.80 Q4 Loss Despite 230% Revenue Surge to $14.2M 41 minutes ago SuRo Capital Corp (SSSS) Reports Wider Loss Q4 Estimates by 10.0% 46 minutes ago BioNTech (BNTX) Posts Q4 Loss of $-1.25/Share as Revenue Falls 23.8% YoY to $907.4M 4 minutes ago Cullinan Therapeutics (CGEM) Reports Q4 Loss of $0.77 Per Share, Flat Year-Over-Year 9 minutes ago Tenax Therapeutics Inc (TENX) Reports Q4 Earnings 11 minutes ago Opus Genetics Inc. (IRD) Reports FY25 Earnings 15 minutes ago Apyx Medical (APYX) Q4 Revenue Jumps 34.8% to $19.2M, Loss Narrows to $0.06/Share 21 minutes ago Cullinan Therapeutics Inc (CGEM) Reports Q4 Earnings 27 minutes ago Prelude Therapeutics Inc (PRLD) Reports Wider Loss for FY25 vs. Estimates 34 minutes ago Prelude Therapeutics (PRLD) Q4 Loss Widens 616.7% to $1.29/Share as Revenue Climbs to $12.1M 38 minutes ago Opus Genetics (IRD) Reports $0.80 Q4 Loss Despite 230% Revenue Surge to $14.2M 41 minutes ago SuRo Capital Corp (SSSS) Reports Wider Loss Q4 Estimates by 10.0% 46 minutes ago
ADVERTISEMENT
Breaking News

Priority Technology (PRTH) reports Q4 Adjusted EPS of $0.11, Revenue Up 8.8%

Priority Technology Holdings posted Q4 adjusted EPS of $0.27, up 621% year-over-year, with revenue climbing 8.8% to $247.1 million.

$FIS $PRTH $PYPL $SQ March 10, 2026 2 min read
NYSE
$FIS · Earnings

Priority Technology Holdings posted Q4 adjusted EPS of $0.27, up 621% year-over-year, with revenue climbing 8.8% to $247.1 million.

Earnings Per Share (adj.)
$0.11
estimate N/A
Revenue
$247.1M
estimate N/A

Adjusted EPS holds flat. Priority Technology Holdings reported adjusted earnings per share of $0.27 for Q4 2025, matching the prior quarter’s $0.27 and surging 621.3% from the year-ago loss of $0.02 per share. The payments technology provider generated adjusted net income of $22.3 million and adjusted EBITDA of $60.1 million in the quarter. On a GAAP basis, diluted EPS came in at $0.11 with net income of $8.9 million.

Revenue climbs 8.8% year-over-year. Q4 2025 revenue reached $247.1 million, up from $227.1 million in the year-ago quarter, marking 8.8% growth. The top line also edged higher sequentially from Q3’s $241.4 million. Gross profit totaled $93.1 million against cost of revenue of $146.9 million, while operating income hit $33.5 million. Management issued full-year 2026 revenue guidance of $1.01 billion to $1.04 billion, signaling confidence in sustained growth momentum.

What to Watch: The company hosts its earnings call today at 10:00 AM ET to detail the drivers behind the year-over-year turnaround and provide color on the $1.01-$1.04 billion revenue outlook for 2026. Listen for commentary on payment volume trends and margin trajectory as the business scales.

This article was generated using AlphaStreet’s proprietary financial analysis technology and reviewed by our editorial team.

ADVERTISEMENT
Tags: #PRTH